Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Wareham

Showing results (471-480 of 904) with videos related to

Pageof 91
Sort By:
Annals of Internal Medicine|May 2, 2007
Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-NorfolkWim A van der Steeg, S Matthijs Boekholdt, Evan A Stein, et al.
Health Technology Assessment (Winchester, England)|September 2, 2016
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) studyRebecca K Simmons, Knut Borch-Johnsen, Torsten Lauritzen, et al.
Human Molecular Genetics|November 25, 2005
IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancerAli Al-Zahrani, Manjinder S Sandhu, Robert N Luben, et al.
Cell Reports|November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's DiseaseJohannes Hertel, Amy C Harms, Almut Heinken, et al.
Diabetes|December 24, 2009
Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes riskKatherine A Fawcett, Eleanor Wheeler, Andrew P Morris, et al.
Journal of the American College of Cardiology|February 12, 2008
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studiesWim A van der Steeg, Ingar Holme, S Matthijs Boekholdt, et al.
BMJ Open Diabetes Research & Care|December 15, 2020
Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational studyEmma Barron, Shivani Misra, Emma English, et al.
The American Journal of Clinical Nutrition|May 4, 2012
Influence of dietary protein intake and glycemic index on the association between TCF7L2 HapA and weight gainEva Fisher, Karina Meidtner, Lars Angquist, et al.
Diabetologia|January 11, 2020
A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trialArun Nanditha, Hazel Thomson, Priscilla Susairaj, et al.
Journal of Glaucoma|July 14, 2018
A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye StudyAnthony P Khawaja, Michelle P Y Chan, Jennifer L Y Yip, et al.
Pageof 91

Showing results (471-480 of 904) with videos related to

Sort By:
Pageof 91
Annals of Internal Medicine|May 2, 2007
Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-NorfolkWim A van der Steeg, S Matthijs Boekholdt, Evan A Stein, et al.
Health Technology Assessment (Winchester, England)|September 2, 2016
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) studyRebecca K Simmons, Knut Borch-Johnsen, Torsten Lauritzen, et al.
Human Molecular Genetics|November 25, 2005
IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancerAli Al-Zahrani, Manjinder S Sandhu, Robert N Luben, et al.
Cell Reports|November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's DiseaseJohannes Hertel, Amy C Harms, Almut Heinken, et al.
Diabetes|December 24, 2009
Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes riskKatherine A Fawcett, Eleanor Wheeler, Andrew P Morris, et al.
Journal of the American College of Cardiology|February 12, 2008
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studiesWim A van der Steeg, Ingar Holme, S Matthijs Boekholdt, et al.
BMJ Open Diabetes Research & Care|December 15, 2020
Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational studyEmma Barron, Shivani Misra, Emma English, et al.
The American Journal of Clinical Nutrition|May 4, 2012
Influence of dietary protein intake and glycemic index on the association between TCF7L2 HapA and weight gainEva Fisher, Karina Meidtner, Lars Angquist, et al.
Diabetologia|January 11, 2020
A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trialArun Nanditha, Hazel Thomson, Priscilla Susairaj, et al.
Journal of Glaucoma|July 14, 2018
A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye StudyAnthony P Khawaja, Michelle P Y Chan, Jennifer L Y Yip, et al.
Pageof 91